Literature DB >> 9175943

Urinary excretion of 5-L-oxoproline (pyroglutamic acid) during early life in term and preterm infants.

A A Jackson1, C Persaud, M Hall, S Smith, N Evans, N Rutter.   

Abstract

Urinary 5-L-oxoproline was measured in term and preterm infants from shortly after birth until 6 weeks of postnatal age to determine their ability to synthesise glycine. In term infants the excretion was five to 10 times that seen in normal adults, increasing from 105 mumol/mmol creatinine in the first 72 hours after birth to 170 mumol/mmol creatinine at 6 weeks of age. There was a significant inverse linear correlation between the excretion of 5-L-oxoproline and length of gestation or birthweight. By 6 weeks of age there was no longer a significant difference in 5-L-oxoproline between term and preterm infants. There was no difference in the excretion of 5-L-oxoproline between boys and girls, or between infants fed on human milk or an artificial formula. If, in part, variability in the excretion of 5-L-oxoproline is determined by the extent to which the endogenous formation of glycine is adequate, then glycine formation may be marginal during early life, more so in preterm than in term infants, providing additional evidence that glycine is a conditionally essential amino acid in the neonate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175943      PMCID: PMC1720658          DOI: 10.1136/fn.76.3.f152

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  24 in total

1.  DETOXIFICATION IN THE NEWBORN: THE ABILITY OF THE NEWBORN INFANT TO FORM CONJUGATES WITH GLUCURONIC ACID, GLYCINE, ACETATE AND GLUTATHIONE.

Authors:  M F VEST; R ROSSIER
Journal:  Ann N Y Acad Sci       Date:  1963-12-30       Impact factor: 5.691

2.  "Unessential" nitrogen: a limiting factor for human growth.

Authors:  S E Snyderman; L E Holt; J Dancis; E Roitman; A Boyer; M E Balis
Journal:  J Nutr       Date:  1962-09       Impact factor: 4.798

3.  The effect of certain vitamin deficiencies on glycine biosynthesis.

Authors:  H R ARNSTEIN; V STANKOVIC
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

4.  Urinary organic acids quantitated by age groups in a healthy pediatric population.

Authors:  J A Thompson; B S Miles; P V Fennessey
Journal:  Clin Chem       Date:  1977-09       Impact factor: 8.327

5.  Folate state of premature infants.

Authors:  P M Roberts; D E Arrowsmith; S M Rau; M E Monk-Jones
Journal:  Arch Dis Child       Date:  1969-10       Impact factor: 3.791

Review 6.  The metabolic formation and utilization of 5-oxo-L-proline (L-pyroglutamate, L-pyrrolidone carboxylate).

Authors:  P van der Werf; A Meister
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

7.  Urinary excretion of 5-L-oxoproline (pyroglutamic acid) is increased during recovery from severe childhood malnutrition and responds to supplemental glycine.

Authors:  C Persaud; T Forrester; A A Jackson
Journal:  J Nutr       Date:  1996-11       Impact factor: 4.798

8.  Benzoylalanine: detection and identification of an alanine conjugate with benzoic acid in hyperammonemic patients treated with sodium benzoate.

Authors:  T Shinka; Y Inoue; T Kuhara; M Matsumoto; I Matsumoto
Journal:  Clin Chim Acta       Date:  1985-10-15       Impact factor: 3.786

9.  Urinary excretion of 5-oxoproline (pyroglutamic aciduria) as an index of glycine insufficiency in normal man.

Authors:  A A Jackson; A V Badaloo; T Forrester; J M Hibbert; C Persaud
Journal:  Br J Nutr       Date:  1987-09       Impact factor: 3.718

10.  Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity.

Authors:  D A Worthington-White; M Behnke; S Gross
Journal:  Am J Clin Nutr       Date:  1994-12       Impact factor: 7.045

View more
  7 in total

1.  Massive 5-oxoprolinuria with normal 5-oxoprolinase and glutathione synthetase activities.

Authors:  E Riudor; J A Arranz; R Alvarez; K Carlsson; M del Toro; F Salmerón; F Piñol; E Ristoff; M Sentis; A Larsson
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

2.  Cord blood glutathione depletion in preterm infants: correlation with maternal cysteine depletion.

Authors:  Alice Küster; Illa Tea; Véronique Ferchaud-Roucher; Sabrina Le Borgne; Claire Plouzennec; Norbert Winer; Jean-Christophe Rozé; Richard J Robins; Dominique Darmaun
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

Review 3.  Inborn errors in the metabolism of glutathione.

Authors:  Ellinor Ristoff; Agne Larsson
Journal:  Orphanet J Rare Dis       Date:  2007-03-30       Impact factor: 4.123

4.  Mapping an atlas of tissue-specific Drosophila melanogaster metabolomes by high resolution mass spectrometry.

Authors:  Venkateswara R Chintapalli; Mohammed Al Bratty; Dominika Korzekwa; David G Watson; Julian A T Dow
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

5.  Exploring the Role of Different Neonatal Nutrition Regimens during the First Week of Life by Urinary GC-MS Metabolomics.

Authors:  Angelica Dessì; Antonio Murgia; Rocco Agostino; Maria Grazia Pattumelli; Andrea Schirru; Paola Scano; Vassilios Fanos; Pierluigi Caboni
Journal:  Int J Mol Sci       Date:  2016-02-22       Impact factor: 5.923

6.  Activation of ectopic olfactory receptor 544 induces GLP-1 secretion and regulates gut inflammation.

Authors:  Chunyan Wu; Mi-Young Jeong; Jung Yeon Kim; Giljae Lee; Ji-Sun Kim; Yu Eun Cheong; Hyena Kang; Chung Hwan Cho; Jimin Kim; Min Kyung Park; You Kyoung Shin; Kyoung Heon Kim; Geun Hee Seol; Seung Hoi Koo; GwangPyo Ko; Sung-Joon Lee
Journal:  Gut Microbes       Date:  2021 Jan-Dec

7.  HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell.

Authors:  Gabriel Valentín-Guillama; Sheila López; Yuriy V Kucheryavykh; Nataliya E Chorna; Jose Pérez; Jescelica Ortiz-Rivera; Michael Inyushin; Vladimir Makarov; Aníbal Valentín-Acevedo; Alfredo Quinones-Hinojosa; Nawal Boukli; Lilia Y Kucheryavykh
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.